Assessing the benefit of treatment in chronic inflammatory demyelinating polyneuropathy: the challenges of clinical practice

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	285-288
Journal	Neurodegenerative disease management
Volume	8
Issue number	5
Early online date	18 Sept 2018
DOIs	https://doi.org/10.2217/nmt-2018-0027
Publication status	Published - 1 Oct 2018

Access to Document

@article{81f8a9f659184146a491d915fc31d93c,

title = "Assessing the benefit of treatment in chronic inflammatory demyelinating polyneuropathy: the challenges of clinical practice",

author = "Rajabally, {Yusuf A}",

note = "{\textcopyright} 2018 Future Medicine Ltd. ",

year = "2018",

month = oct,

day = "1",

doi = "10.2217/nmt-2018-0027",

language = "English",

volume = "8",

pages = "285--288",

journal = "Neurodegenerative disease management",

issn = "1758-2024",

publisher = "Future Medicine",

number = "5",

}

TY - JOUR

T1 - Assessing the benefit of treatment in chronic inflammatory demyelinating polyneuropathy: the challenges of clinical practice

AU - Rajabally, Yusuf A

PY - 2018/10/1

Y1 - 2018/10/1

UR - https://www.futuremedicine.com/doi/10.2217/nmt-2018-0027

U2 - 10.2217/nmt-2018-0027

DO - 10.2217/nmt-2018-0027

M3 - Editorial

SN - 1758-2024

VL - 8

SP - 285

EP - 288

JO - Neurodegenerative disease management

JF - Neurodegenerative disease management

IS - 5

ER -